Similar companies
Company | Business Outlook | |
---|---|---|
AmgenAMGN |
77 0% | |
Gilead SciencesGILD |
60 3.4% | |
Catalyst PharmaceuticalsCPRX |
100 0% | |
Anavex Life SciencesAVXL |
0 0% | |
BridgeBio PharmaBBIO |
93 0% |
Month over Month
Employee view on business outlook (0 - 100)
Nov 2024 | 23 | |
Oct 2024 | 23 | |
Sep 2024 | 18 | |
Aug 2024 | 19 |
How do employees feel about the future at Inovio Pharmaceuticals?
According to employees, the Business Outlook at Inovio Pharmaceuticals is highly negative. This is reflected in the average rating of 23 out of 100, which is considered very low.
Analyzing Business Outlook, how is Inovio Pharmaceuticals performing compared to its industry peers?
Inovio Pharmaceuticals underperforms its industry peers when it comes to Business Outlook, ranking in the 23rd percentile.
How has the business outlook at Inovio Pharmaceuticals changed over the last couple of months
In recent months, Inovio Pharmaceuticals' employees have reported a shift towards a more positive business outlook, indicating improved company morale and potentially leading to increased market competitiveness and enhanced company performance.
Why is it important to track the business outlook at Inovio Pharmaceuticals?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Inovio Pharmaceuticals.